Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycoprotein D (gD) is an essential envelope glycoprotein present on the surface of herpes simplex virus (HSV) types 1 and 2, required for viral infectivity and entry into host cells[1][6][7]. gD acts by binding to multiple host cell receptors including nectin-1, herpesvirus entry mediator (HVEM, TNFRSF14), and 3-O-sulfated heparan sulfate, thereby determining the tropism of HSV and facilitating viral fusion with the cell membrane[2][3][4][7]. Binding of gD to a cellular receptor triggers conformational changes that activate other viral glycoproteins (gH/gL and gB), resulting in fusion of the viral and cellular membranes for virus entry[3][4][5]. gD is also a major antigenic target in vaccine development against HSV and in diagnostic assays; neutralizing antibodies against gD can block viral entry and fusion, representing an important antiviral strategy[5]. Structural studies indicate that gD consists of regions responsible for receptor binding and fusion activation, with antigenic and structural differences between HSV-1 and HSV-2 gD variants[1][6].
Blocking gD-receptor interactions to prevent virus entry Neutralizing antibody binding to gD to inhibit infection/fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein D of herpes simplex virus (gD).